Effect of Prophylactic Ketorolac on CME After Cataract Surgery

Status Completed

Clinical Trial Summary

The study will evaluate the efficacy of prophylactic administration of the topical nonsteroidal anti-inflammatory drug (NSAID) ketorolac tromethamine 0.5% (Acular®) on cystoid macular edema (CME) in patients having undergone cataract surgery. CME is the most frequent cause of decreased vision after uncomplicated cataract surgery and can result in irreversible sight reduction. The investigation will involve a comparison arm and a treatment arm with both sets of patient populations being evaluated for CME with ophthalmologic examinations and optical coherence tomography (OCT) measurements. The objective is to elucidate the role of NSAID drops in preventing CME after cataract surgery.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00335439
Study type	Interventional
Source	Queen's University
Contact
Status	Completed
Phase	N/A
Start date	June 2006
Completion date	May 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03559491` - Dexamethasone Intravitreal Implant in Retinal Vein Occlusion
Completed	`NCT00105027` - The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study	Phase 3
Completed	`NCT01546402` - Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema	Phase 4
Completed	`NCT00106132` - Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage	Phase 3
Completed	`NCT04472039` - Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
Terminated	`NCT02665689` - Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab	Phase 4
Completed	`NCT01698749` - Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema	N/A
Completed	`NCT00000115` - Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema	Phase 2
Withdrawn	`NCT00135655` - A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema	Phase 2
Completed	`NCT00001738` - Vascular Endothelial Growth Factor (VEGF) in Uveitis	N/A